VZL-16782-75559
2 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 597 / MT
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-10
Registered in v-safe
-
2021-04-10
Dose 1 — Pfizer-BioNTech
- 2021-04-10
- 2021-04-13
- 2021-04-14
-
2021-05-01
Dose 2 — Pfizer-BioNTech
- 2021-05-01
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-06-07
- 2021-10-30
-
2022-05-01
Survey response — 12 months, dose 2MedDRA: Cough, Dizziness, Dyspnoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough, dizziness, SOBMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Pfizer-BioNTech | |
| 2 | 2021-05-01 | Pfizer-BioNTech |
Free text
Release 11 — 12 months, dose 2
Symptoms: Cough, dizziness, SOB
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release